Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinecke

Showing results (351-360 of 1,735) with videos related to

Pageof 174
Sort By:
Behavior Analysis in Practice|April 20, 2026
Coursework in Compassion and Behavior Analysis Training ProgramsDana Reinecke, Julianne Lasley, Nasiah Cirincione-Ulezi
Behavior Analysis in Practice|July 3, 2025
For the Love of this Field: Advocating and Collaborating with a United PurposeBobbi Rogers, Dana Reinecke, Tricia Moss-Lourenco
Phytochemistry|March 22, 2003
Ecdysteroids and other constituents from Sida spinosa LFaten M M Darwish, Manfred G Reinecke
Cell and Tissue Research|May 1, 1992
Distribution patterns and coexistence of neurohormonal peptides (ANP, BNP, NPY, SP, CGRP, enkephalins) in chromaffin cells and nerve fibers of the anuran adrenal organM Reinecke, C Heym, W G Forssmann
Cell and Tissue Research|January 1, 1984
Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nervesE Weihe, M Reinecke, W G Forssmann
Neuroscience Letters|December 1, 1980
Substance P-immunoreactive nerve fibers in the heartM Reinecke, E Weihe, W G Forssmann
Investigative Ophthalmology & Visual Science|August 1, 1992
Visual acuities and scotomas after one week levodopa administration in human amblyopiaI Gottlob, J Charlier, R D Reinecke
Physical Review. B, Condensed Matter|December 15, 1995
Carrier-distribution-dependent band-gap renormalization in modulation-doped quantum wellsWang, Shah, Damen, et al.
Cognition|November 10, 2024
Developmental changes in the perceived moral standing of robotsMadeline G Reinecke, Matti Wilks, Paul Bloom
Stroke|September 7, 2013
Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulantsHolger Reinecke, Christiane Engelbertz, Wolf-Rüdiger Schäbitz
Pageof 174

Showing results (351-360 of 1,735) with videos related to

Sort By:
Pageof 174
Behavior Analysis in Practice|April 20, 2026
Coursework in Compassion and Behavior Analysis Training ProgramsDana Reinecke, Julianne Lasley, Nasiah Cirincione-Ulezi
Behavior Analysis in Practice|July 3, 2025
For the Love of this Field: Advocating and Collaborating with a United PurposeBobbi Rogers, Dana Reinecke, Tricia Moss-Lourenco
Phytochemistry|March 22, 2003
Ecdysteroids and other constituents from Sida spinosa LFaten M M Darwish, Manfred G Reinecke
Cell and Tissue Research|May 1, 1992
Distribution patterns and coexistence of neurohormonal peptides (ANP, BNP, NPY, SP, CGRP, enkephalins) in chromaffin cells and nerve fibers of the anuran adrenal organM Reinecke, C Heym, W G Forssmann
Cell and Tissue Research|January 1, 1984
Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nervesE Weihe, M Reinecke, W G Forssmann
Neuroscience Letters|December 1, 1980
Substance P-immunoreactive nerve fibers in the heartM Reinecke, E Weihe, W G Forssmann
Investigative Ophthalmology & Visual Science|August 1, 1992
Visual acuities and scotomas after one week levodopa administration in human amblyopiaI Gottlob, J Charlier, R D Reinecke
Physical Review. B, Condensed Matter|December 15, 1995
Carrier-distribution-dependent band-gap renormalization in modulation-doped quantum wellsWang, Shah, Damen, et al.
Cognition|November 10, 2024
Developmental changes in the perceived moral standing of robotsMadeline G Reinecke, Matti Wilks, Paul Bloom
Stroke|September 7, 2013
Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulantsHolger Reinecke, Christiane Engelbertz, Wolf-Rüdiger Schäbitz
Pageof 174